Tom Zapatinas - PreAxia Health CEO, CFO, Director
| PAXH Stock | USD 0.06 0.00 0.00% |
CEO
Mr. Tom Zapatinas is the President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary and Director of PreAxia Health Care Payment Systems Inc. He was a director of company since January 9, 2007 and the president, secretary and chief executive officer of company since January 25, 2008. Mr. Zapatinas was a director of our Company since January 9, 2007 and the president, secretary, chief executive officer and chief financial officer of our company since January 25, 2008. Mr. Zapatinas was a selfemployed business consultant since August, 1997. In June of 1998, Mr. Zapatinas founded Prolific Smart Card Software Systems Inc. which became a reporting issuer on the TSX Venture Exchange in Canada since 2016.
| Age | 67 |
| Tenure | 8 years |
| Phone | 403 850 4120 |
| Web | https://www.preaxia.com |
PreAxia Health Management Efficiency
The company has return on total asset (ROA) of (782.986) % which means that it has lost $782.986 on every $100 spent on assets. This is way below average. PreAxia Health's management efficiency ratios could be used to measure how well PreAxia Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | CEO Age | ||
| Vincent Kelly | Spok Holdings | 64 | |
| Vincent CPA | Spok Holdings | 64 | |
Management Performance
| Return On Asset | -782.99 |
PreAxia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is PreAxia Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -782.99 | |||
| Current Valuation | 2.81 M | |||
| Shares Outstanding | 19.77 M | |||
| Shares Owned By Insiders | 46.03 % | |||
| Price To Earning | (50.00) X | |||
| Price To Sales | 3,416 X | |||
| Revenue | 368 | |||
| Gross Profit | 368 | |||
| EBITDA | (180.64 K) | |||
| Net Income | (180.64 K) |
Currently Active Assets on Macroaxis
Other Information on Investing in PreAxia Pink Sheet
PreAxia Health financial ratios help investors to determine whether PreAxia Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PreAxia with respect to the benefits of owning PreAxia Health security.